Petekkaya, I. Et Al. 2012. Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients. JOURNAL OF BUON , vol.17 , 800.

Petekkaya, I., Akin, T., Gezgen, G., Roach, E. C. , Ozisik, Y., & Altundag, K., (2012). Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients. JOURNAL OF BUON , vol.17, 800.

Petekkaya, I. Et Al. "Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients," JOURNAL OF BUON , vol.17, 800, 2012

Petekkaya, I. Et Al. "Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients." JOURNAL OF BUON , vol.17, pp.800, 2012

Petekkaya, I. Et Al. (2012) . "Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients." JOURNAL OF BUON , vol.17, p.800.

@article{article, author={I. Petekkaya Et Al. }, title={Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients}, journal={JOURNAL OF BUON}, year=2012, pages={800} }